H1N1 Influenza Clinical Trial
Official title:
The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A: a Randomized-controlled Trial
Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1
influenza virus first appeared in Mexico and the United States in March and April 2009 and
has swept the globe with unprecedented speed.
The aim of this study is to evaluate effect of supplement vitamin on the clinical course of
patients with acute respiratory illness suspected novel H1N1 infection.
Patients with acute respiratory illness randomized to control or vitamin groups. The patients completed questionnaire about their initial symptom scores. After 5 days of vitamin trial, patients were asked about their symptom by telephone survey. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641690 -
Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
|
||
Terminated |
NCT00970606 -
STIP: Statin Trial for Influenza Patients
|
N/A | |
Completed |
NCT02921997 -
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
|
Phase 2 | |
Recruiting |
NCT01008683 -
Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation
|
N/A | |
Completed |
NCT01011582 -
Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
|
N/A | |
Active, not recruiting |
NCT01421251 -
H1N1 Vaccine Safety in Manitoba, Canada
|
N/A | |
Recruiting |
NCT04497311 -
Tomographic Findings in COVID-19 and Influenza
|
||
Completed |
NCT04933994 -
Comparison of COVID-19 and H1N1 Influenza Pneumonia
|
||
Completed |
NCT01002040 -
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
|
Phase 4 | |
Terminated |
NCT01798602 -
Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial
|
Phase 2 | |
Terminated |
NCT04810949 -
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
|
N/A | |
Completed |
NCT05080933 -
ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS
|